<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03294369</url>
  </required_header>
  <id_info>
    <org_study_id>RICARTO</org_study_id>
    <nct_id>NCT03294369</nct_id>
  </id_info>
  <brief_title>CV Risk and Toledo</brief_title>
  <acronym>RICARTO</acronym>
  <official_title>RIesgo CARdiovascular y Eventos Cardiovasculares en la población General Del área Sanitaria de TOledo</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Carlos Escobar</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>FISCAM</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>La Sociedad Española de Médicos de Atención Primaria</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>La Sociedad Española de Médicos de Atención Primaria</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This epidemiological and observational study is aimed to assess cardiovascular risk (CVR) by
      investigating the prevalence of CVR factors (CVRF), target organ damage (TOD) and
      cardiovascular disease (CVD) in general population of the sanitary area of Toledo.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Epidemiological and observational study that is analyzing a sample from the general
      population aged 18 years or older, randomly selected from a database of sanitary cards
      stratified by age and gender.

      Clinical history, physical examination and complementary tests are being performed.

      Total blood and serum samples are being frozen (-85ºC) for future genetic studies.

      CVR is assessed by SCORE scale calibrated for Spanish population and the Framingham Heart
      Study scale.

      Patients will be periodically visited, with a minimum follow-up of 5 years. Standard
      statistical analysis will be performed.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 1, 2011</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>5 Years</target_duration>
  <primary_outcome>
    <measure>Assess cardiovascular risk of the study population</measure>
    <time_frame>December 2020</time_frame>
    <description>Cardiovascular risk will be determined according to SCORE scale calibrated for Spanish population and the Framingham Heart Study scale.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Prevalence of cardiovascular risk factors</measure>
    <time_frame>December 2020</time_frame>
    <description>To assess the prevalence of cardiovascular risk factors</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Prevalence of cardiovascular disease</measure>
    <time_frame>December 2020</time_frame>
    <description>To assess the prevalence of cardiovascular disease</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">3125</enrollment>
  <condition>Cardiovascular Risk Factor</condition>
  <condition>Cardiovascular Diseases</condition>
  <arm_group>
    <arm_group_label>Cohort of the study</arm_group_label>
    <description>A sample from the general population aged 18 years or older, randomly selected from a database of sanitary cards stratified by age and gender.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Observational</intervention_name>
    <description>This is an observational study. No specific diagnostic or therapeutic procedure will be performed due to the study.</description>
    <arm_group_label>Cohort of the study</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Total blood and serum samples will be frozen (-85ºC) for future genetic studies.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects aged 18 years or older, randomly selected from a database of health cards
        stratified by age and gender
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects aged 18 years or older, randomly selected from a database of health cards
             stratified by age and gender

        Exclusion Criteria:

          -  Individulas aged under 18 years.

          -  Subjects who do not sign the informed consent.

          -  Subjects that due to different conditions (physical, mental or social) is expected
             that do not complete the expected follow-up.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Goya, 25</name>
      <address>
        <city>Madrid</city>
        <zip>28001</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carlos Escobar, MD, PhD</last_name>
      <email>escobar_cervantes_carlos@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <results_reference>
    <citation>Rodríguez-Roca GC, Segura-Fragoso A, Villarín-Castro A, Alonso-Moreno FJ, Rodríguez-Padial L, Rodríguez-García ML, Fernández-Conde JA, Rojas-Martelo GA, Menchén-Herreros A, Escobar-Cervantes C, Fernández-Martín J, Artigao-Rodenas LM, Carbayo-Herencia JA, Hernández-Moreno J; en representación del grupo de trabajo RICARTO. [Characteristics and cardiovascular events in a general population included in the RICARTO (RIesgo CARdiovascular TOledo) study: Data from the first 1,500 individuals included in the study]. Semergen. 2018 Apr;44(3):180-191. doi: 10.1016/j.semerg.2017.07.002. Epub 2017 Aug 30. Spanish.</citation>
    <PMID>28869129</PMID>
  </results_reference>
  <results_reference>
    <citation>Rodríguez-Roca GC, Rodríguez-Padial L, Alonso-Moreno FJ, Segura-Fragoso A, Villarín-Castro A, Rodríguez-García ML, Menchén-Herreros A, Rojas-Martelo GA, Fernández-Conde JA, Artigao-Rodenas LM, Carbayo-Herencia JA, Escobar-Cervantes C, Hernández-Moreno J, Fernández-Martín J; en representación del grupo de trabajo RICARTO. [Cardiovascular risk and cardiovascular events in the general population of the sanitary area of Toledo. RICARTO Study]. Semergen. 2018 Mar;44(2):107-113. doi: 10.1016/j.semerg.2017.04.007. Epub 2017 May 27. Spanish.</citation>
    <PMID>28566229</PMID>
  </results_reference>
  <results_reference>
    <citation>Rodriguez-Roca GC, Villarín-Castro A, Carrasco-Flores J, Artigao-Rodenas LM, Carbayo-Herencia JA, Escobar-Cervantes C, Alonso-Moreno FJ, Segura-Fragoso A, Gómez-Serranillos M, Hernández-Moreno J; RICARTO (Riesgo Cardiovascular Y Eventos Cardiovasculares En La Población General del Área Sanitaria De Toledo) Project Working Group. Concordance between automated oscillometric measurement of ankle-brachial index and traditional measurement by eco-Doppler in patients without peripheral artery disease. Blood Press. 2014 Oct;23(5):270-5. doi: 10.3109/08037051.2013.876796. Epub 2014 Mar 19.</citation>
    <PMID>24646328</PMID>
  </results_reference>
  <results_reference>
    <citation>Rodríguez-Roca GC, Rodríguez-Padial L, Alonso-Moreno FJ, Romero-Gutiérrez A, Akerström F, Segura-Fragoso A, Villarín-Castro A, Hernández-Moreno J, Menchén-Herreros A, Gómez-Serranillos M, Artigao-Rodenas LM; grupo de trabajo del estudio RICARTO. [Lipid profile in patients admitted with acute coronary syndrome in Spain: data from Toledo health care area between 2005 and 2008]. Semergen. 2013 Sep;39(6):298-303. doi: 10.1016/j.semerg.2012.11.001. Epub 2012 Dec 20. Spanish.</citation>
    <PMID>24034757</PMID>
  </results_reference>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 22, 2017</study_first_submitted>
  <study_first_submitted_qc>September 22, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">September 27, 2017</study_first_posted>
  <last_update_submitted>September 22, 2017</last_update_submitted>
  <last_update_submitted_qc>September 22, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 27, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>La Sociedad Española de Médicos de Atención Primaria</investigator_affiliation>
    <investigator_full_name>Carlos Escobar</investigator_full_name>
    <investigator_title>Gustavo C Rodriguez Roca</investigator_title>
  </responsible_party>
  <keyword>Hypertension</keyword>
  <keyword>Diabetes</keyword>
  <keyword>Dyslipidemia</keyword>
  <keyword>Smoking</keyword>
  <keyword>Cardiovascular</keyword>
  <keyword>Toledo</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

